• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Janssen US Medical Affairs - Merging??


<











This doesn’t make sense strategically. The only thing preventing medical affairs and commercial from working more closely than they do is this big old thing called regulatory and compliance. Why would an organization voluntarily separate the two